Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines

a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)

Kieran R. Manchester, Emma C. Lomas, Laura Waters, Fiona C. Dempsey, Peter D. Maskell

    Research output: Contribution to journal › Comment/debate

    5 Citations (Scopus)

    Abstract

    This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).

    Original languageEnglish
    Pages (from-to)392-393
    Number of pages2
    JournalDrug Testing and Analysis
    Volume10
    Issue number2
    DOIs
    Publication statusPublished - 1 Jan 2018

    Fingerprint

    Benzodiazepines
    drug
    Testing
    Pharmaceutical Preparations
    water
    Water
    analysis
    test
    patent

    Cite this

    Manchester, Kieran R. ; Lomas, Emma C. ; Waters, Laura ; Dempsey, Fiona C. ; Maskell, Peter D. / Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines : a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211). In: Drug Testing and Analysis. 2018 ; Vol. 10, No. 2. pp. 392-393.
    @article{9e4b5ccac65e47928e385f0defe0cda4,
    title = "Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)",
    abstract = "This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).",
    author = "Manchester, {Kieran R.} and Lomas, {Emma C.} and Laura Waters and Dempsey, {Fiona C.} and Maskell, {Peter D.}",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.1002/dta.2349",
    language = "English",
    volume = "10",
    pages = "392--393",
    journal = "Drug Testing and Analysis",
    issn = "1942-7603",
    publisher = "John Wiley and Sons Ltd",
    number = "2",

    }

    Manchester, KR, Lomas, EC, Waters, L, Dempsey, FC & Maskell, PD 2018, 'Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)', Drug Testing and Analysis, vol. 10, no. 2, pp. 392-393. https://doi.org/10.1002/dta.2349

    Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines : a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211). / Manchester, Kieran R.; Lomas, Emma C.; Waters, Laura; Dempsey, Fiona C.; Maskell, Peter D.

    In: Drug Testing and Analysis, Vol. 10, No. 2, 01.01.2018, p. 392-393.

    Research output: Contribution to journal › Comment/debate

    TY - JOUR

    T1 - Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines

    T2 - a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)

    AU - Manchester, Kieran R.

    AU - Lomas, Emma C.

    AU - Waters, Laura

    AU - Dempsey, Fiona C.

    AU - Maskell, Peter D.

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).

    AB - This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).

    U2 - 10.1002/dta.2349

    DO - 10.1002/dta.2349

    M3 - Comment/debate

    VL - 10

    SP - 392

    EP - 393

    JO - Drug Testing and Analysis

    JF - Drug Testing and Analysis

    SN - 1942-7603

    IS - 2

    ER -

    Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211). Drug Testing and Analysis. 2018 Jan 1;10(2):392-393. https://doi.org/10.1002/dta.2349

    Access to Document